Wang Zeng-shou

424 total citations
12 papers, 277 citations indexed

About

Wang Zeng-shou is a scholar working on Pharmacology, Molecular Biology and Molecular Medicine. According to data from OpenAlex, Wang Zeng-shou has authored 12 papers receiving a total of 277 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pharmacology, 3 papers in Molecular Biology and 3 papers in Molecular Medicine. Recurrent topics in Wang Zeng-shou's work include Curcumin's Biomedical Applications (3 papers), Fibroblast Growth Factor Research (2 papers) and Pharmacogenetics and Drug Metabolism (2 papers). Wang Zeng-shou is often cited by papers focused on Curcumin's Biomedical Applications (3 papers), Fibroblast Growth Factor Research (2 papers) and Pharmacogenetics and Drug Metabolism (2 papers). Wang Zeng-shou collaborates with scholars based in China, United Kingdom and United States. Wang Zeng-shou's co-authors include Guanghui Zhu, Guang Liang, Xiaokun Li, Yuepiao Cai, Yilan Li, Yong Pan, Jie Hu, Guoxin Hu, Wei Sun and Lu Cai and has published in prestigious journals such as Anesthesiology, Signal Transduction and Targeted Therapy and BioMed Research International.

In The Last Decade

Wang Zeng-shou

12 papers receiving 274 citations

Peers

Countries citing papers authored by Wang Zeng-shou

Since Specialization

Citations

This map shows the geographic impact of Wang Zeng-shou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wang Zeng-shou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wang Zeng-shou more than expected).

Fields of papers citing papers by Wang Zeng-shou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wang Zeng-shou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wang Zeng-shou. The network helps show where Wang Zeng-shou may publish in the future.

Co-authorship network of co-authors of Wang Zeng-shou

This figure shows the co-authorship network connecting the top 25 collaborators of Wang Zeng-shou. A scholar is included among the top collaborators of Wang Zeng-shou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wang Zeng-shou. Wang Zeng-shou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

#	Work	Indexed citations
1	A non-mitogenic FGF4 analog alleviates non-alcoholic steatohepatitis through an AMPK-dependent pathway 2022 ·Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease ·Luyao Wang, (unknown), Huan Gao, Chuchu Chen, Siyu Liang, (unknown), Yi Liu, Yushu Hou, Lei Fan, Tongtong Pan, Wang Zeng-shou, Yongping Chen, Yongde Luo, Lintao Song	8
2	FGF1ΔHBS prevents diabetic cardiomyopathy by maintaining mitochondrial homeostasis and reducing oxidative stress via AMPK/Nur77 suppression 2021 ·Signal Transduction and Targeted Therapy ·Dezhong Wang, Yuan Yin, Shu‐Yi Wang, Tianyang Zhao, Fanghua Gong, (unknown), Beibei Wang, (unknown), (unknown), Guanghui Zhu, Wang Zeng-shou, Yang Wang, Jun Ren, Guang Liang, Xiaokun Li, Zhifeng Huang	81
3	PPARγ Mediates the Anti-Epithelial-Mesenchymal Transition Effects of FGF1ΔHBS in Chronic Kidney Diseases via Inhibition of TGF-β1/SMAD3 Signaling 2021 ·Frontiers in Pharmacology ·Dezhong Wang, Tianyang Zhao, (unknown), Yuan Yin, Yuli Huang, (unknown), Beibei Wang, (unknown), (unknown), (unknown), Wang Zeng-shou, Guanghui Zhu	6
4	Investigation of the effects of axitinib on the pharmacokinetics of loperamide and its main metabolite N-demethylated loperamide in rats by UPLC-MS/MS 2019 ·Chemico-Biological Interactions ·(unknown), (unknown), Yinghui Li, (unknown), Xiaodan Zhang, Guoxin Hu, Wang Zeng-shou	4
5	In Vitro and In Vivo Characterization of 13 CYP2C9 Allelic Variants Found in Chinese Han Population 2015 ·Drug Metabolism and Disposition ·(unknown), (unknown), Wang Zeng-shou, Liping Yang, Da‐Peng Dai, Shuanghu Wang, (unknown), Xiangjun Qiu, Tao Xu, Jun Luo, Qingquan Lian, Ren‐Shan Ge, Jianping Cai	12
6	Pharmacokinetics Interaction between Imatinib and Genistein in Rats 2015 ·BioMed Research International ·Zhe Wang, Li Wang, Mengming Xia, Wei Sun, (unknown), Xiao Cui, Guoxin Hu, Qingquan Lian, Wang Zeng-shou	10
7	Enhancement of Oral Bioavailability of Curcumin Loaded PLGA Nanoparticles 2014 ·Yi Zheng, (unknown), Wang Zeng-shou	1
8	Inhibitory effects of curcumin on activity of cytochrome P450 2C9 enzyme in human and 2C11 in rat liver microsomes 2014 ·Drug Development and Industrial Pharmacy ·Zhe Wang, Wei Sun, (unknown), Li Wang, (unknown), Mengming Xia, Guoxin Hu, Wang Zeng-shou	43
9	UPLC–MS/MS determination of thiamphenicol in human plasma and its application to a pharmacokinetic study 2014 ·Journal of Chromatography B ·Zhe Wang, Hui Yang, Wei Sun, (unknown), Xiao Cui, Xiangjun Qiu, Qingquan Lian, Wang Zeng-shou	7
10	Attenuation of high-glucose-induced inflammatory response by a novel curcumin derivative B06 contributes to its protection from diabetic pathogenic changes in rat kidney and heart 2012 ·The Journal of Nutritional Biochemistry ·Yong Pan, Guanghui Zhu, Yi Wang, Lu Cai, Yuepiao Cai, Jie Hu, Yilan Li, (unknown), Wang Zeng-shou, Xiaokun Li, Tiemin Wei, Guang Liang	80
11	Determination of the Content of Aristolochic Acid Iand II in Ganluxiaodu Pills with RP-HPLC 2006 ·Yiyao daobao ·(unknown), Qizhi Wang, Wang Zeng-shou, (unknown)	1
12	Pharmacokinetics of a Single Bolus of Propofol in Chinese Children of Different Ages 2005 ·Anesthesiology ·(unknown), Qingquan Lian, Leon Aarons, (unknown), Wang Zeng-shou, Xiaolin Chen, Nick Freemantle, Fang Gao Smith	24

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact